Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Brent P. Forester, Sagar V. Parikh, Sara L. Weisenbach, et al.
American Journal of Geriatric Psychiatry (2020) Vol. 28, Iss. 9, pp. 933-945
Open Access | Times Cited: 21

Showing 21 citing articles:

Pharmacogenomics: Driving Personalized Medicine
Wolfgang Sadée, Daqing Wang, Katherine E. Hartmann, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 789-814
Open Access | Times Cited: 79
Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis
Mary Bunka, Gavin Wong, Daniel Kim, et al.
Psychiatry Research (2023) Vol. 321, pp. 115102-115102
Open Access | Times Cited: 19
Pharmacogenomic Clinical Support Tools for the Treatment of Depression
Matthew L. Baum, Alik S. Widge, Linda L. Carpenter, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 7, pp. 591-607
Closed Access | Times Cited: 7
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
Victoria S. Marshe, Małgorzata Maciukiewicz, Anne-Christin Hauschild, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Optimizing the Treatment of Late-Life Depression
Art Walaszek
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 7-10
Closed Access | Times Cited: 4
Evaluating The Effectiveness of Pharmacogenomics-Based Care in Depression Compared to Standard Care: A Review of Current Evidence
Chinonyelum Emmanuel Agbo, Ikponmwosa Jude Ogieuhi, Chidera Stanley Anthony, et al.
Current Treatment Options in Psychiatry (2025) Vol. 12, Iss. 1
Closed Access
Effectiveness of pharmacological and non-pharmacological interventions for treatment-resistant depression in older patients: a systematic review and meta-analysis
A Larsen, Giulia Teobaldi, Rosario Isabel Espinoza Jeraldo, et al.
BMJ Mental Health (2025) Vol. 28, Iss. 1, pp. e301324-e301324
Open Access
Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis
Kiflu Gebremicael Tesfamicael, Lijun Zhao, Rubén Fernández‐Rodríguez, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression
Malcolm Forbes, Adrienne O’Neil, Melissa M. Lane, et al.
Drugs & Aging (2021) Vol. 38, Iss. 6, pp. 451-467
Closed Access | Times Cited: 19
Integration of a pharmacist-led pharmacogenomic service in a geriatric clinic: Barriers and outcomes
Alayna M. Kehr, Gina Ayers, Saket Saxena, et al.
Journal of the American Pharmacists Association (2023) Vol. 63, Iss. 3, pp. 778-784
Closed Access | Times Cited: 6
Perspectives in Psychopharmacology

FOCUS The Journal of Lifelong Learning in Psychiatry (2021) Vol. 19, Iss. 1, pp. 71-72
Open Access | Times Cited: 11
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review
Pasquale Paribello, Mirko Manchia, Federica Pinna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4776-4776
Open Access | Times Cited: 4
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.

PubMed (2021) Vol. 21, Iss. 13, pp. 1-214
Closed Access | Times Cited: 10
Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results
John Loftus, Howard P. Levy, James M. Stevenson
Genetics in Medicine (2023) Vol. 26, Iss. 4, pp. 101056-101056
Closed Access | Times Cited: 3
Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership
Chad A. Bousman, Anita Oomen, Chaten D. Jessel, et al.
American Journal of Geriatric Psychiatry (2021) Vol. 30, Iss. 5, pp. 560-571
Closed Access | Times Cited: 7
Research into ageing and frailty
Adam Gordon, Miles D. Witham, Emily J. Henderson, et al.
Future Healthcare Journal (2021) Vol. 8, Iss. 2, pp. e237-e242
Open Access | Times Cited: 7
Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report
Nicole Marie Del Toro-Pagán, Adriana Matos, David Thacker, et al.
Medicina (2021) Vol. 57, Iss. 9, pp. 955-955
Open Access | Times Cited: 5
Impact of Pharmacogenomics Testing on Response to Antidepressants and Antipsychotics - A Systematic Review
Sarah Alhaddad, Christian N Paulsingh, Faisal Riaz, et al.
Journal For International Medical Graduates (2024) Vol. 1, Iss. 1
Open Access
Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review
Angela Wu, Edward Raack, Colin J.D. Ross, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders
Laura B. Teal, Shalonda Ingram, Michael Bubser, et al.
Advances in neurobiology (2023), pp. 37-99
Closed Access | Times Cited: 1
Translational Pharmacogenomics Augmenting Pharmacotherapy
Kalyan Ram Uppaluri
(2023)
Open Access
Page 1

Scroll to top